ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Labcorp at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Labcorp takes part in 2 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1088. Its work centres on cancer biomarkers and laboratory testing in ovarian cancer and chronic lymphocytic leukemia. The studies examine how ovarian tumour features relate to PD-L1 staining and validate a blood test panel measuring CD20 during treatment.
| Organization | ESMO 2026 Attendance |
|---|---|
Clinical laboratory company offering diagnostic testing, including oncology tests, and central-laboratory services for drug development. | Booth Exhibiting at Booth 1088 Poster Mon Oct 26 12:00–12:45 Histotype, mutational, and immune gene expression correlates of PD-L1 immunohistochemistry in real-world cohort of ovarian cancer cases Gynaecological cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Validation of a multiparametric flow cytometry panel for quantifying CD20 expression in CLL whole blood during mosunetuzumab therapy Haematological malignanciesBiomarkers & precision oncology |
Find decision makers at Labcorp
Tell us what you sell and we’ll find the people at Labcorp most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction